Tolerability and antiviral effects in a 28-day study of the hepatitis C protease inhibitor Telaprevir (VX-950), in combination with peg-interforon-alpha-2a and ribavirin
JOURNAL OF CLINICAL VIROLOGY（2006）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined